AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet
Clicks: 245
ID: 269770
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
245 views
71 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #24 of 30 articles by views in intensive care medicine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (18 words).
Try re-searching for a better abstract.
| Reference Key |
hj2018intensiveaki
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | de Grooth HJ;Parienti JJ;Schetz M;; |
| Journal | intensive care medicine |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
pubmed abstract
nih
national institutes of health
national library of medicine
biomarkers*
comment
editorial
pmid:29651499
doi:10.1007/s00134-018-5151-7
harm-jan de grooth
jean-jacques parienti
miet schetz
acute kidney injury
renal replacement therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.